摘要
目的探讨酚妥拉明联合血凝酶治疗支气管扩张大咯血的临床效果。方法选择53例患者,其中观察组26例观察组使用酚妥拉明联合血凝酶治疗,对照组27例单纯使用酚妥拉明治疗,比较两组患者临床效果及不良反应发生情况。结果观察组有效率显著高于对照组(P<0.05),观察组出现血压降低、心悸、胃肠道不适和头痛的比率均显著少于对照组(P<0.05)。结论酚妥拉明联合血凝酶治疗支气管扩张大咯血,临床效果显著且不良反应少,值得临床推广。
Objective To investigate the effect of phentolamine combined with hemocoagulase for hemoptysis caused by bronchiectasis. Methods 53 cases were randomly divided into two groups, the nbservalion group （26 cases） were used phentolamine combined with hemocoagulase, the control group（27 cases） were only treated with phentolamine, then the clinieal efficacy and adverse reaction were compared with the two groups. Results In the ohservalion group the efficiency was higher than control group（P 〈 0.05 ）, decreased blood pressure, heart palpitations, gastrointestinal discomfort and headache ratios were less than control group （ P 〈 0.05 ）. Conclusion The phentolamine combined with hemocoagulase therapy for bronchiectasis with massive hemuptysis is efficacy and it has less adverse reactions, so it is worthy of clinical application.
出处
《中国医药科学》
2013年第6期72-73,共2页
China Medicine And Pharmacy
关键词
酚妥拉明
血凝酶
支气管扩张
大咯血
Phentolamine
Hemocoagulase
Bronchiectasis
Hemoptysis
